Home > FDA Warnings > FDA Update on Avoiding Gadolinium Used in MRI Get the Flash Player to see this player. Rate: (Click the stars to rate) Published on Oct 01, 2008 by Rodrigo Duarte, Views: 6189 Gadolinium, which is commonly used during an MRI as a contrast agent, have a new FDA warning that they can cause NSF/NFD, nephrogenic systemic Fibrosis/Nephrogenic Fibrosing Dermopathy. These are diseases which cause fibrosis of the skin and internal organs. These problems can occur from a few days to a year after receiving the contrast agent. This videos tell you who is at risk and what the signs are. I am so upset to be reading this. I have an MRI every year. If they see something on my MRI, I have to have a needle guided biopsy. This has happened too many times in the past few years since I have been diagnosed with LCIS. My doctor who is at Sloan Kettering in New York City seems very competent. Now, I do not know if I want to go back. She says I will never die from breast cancer if I get this test. Should I be worried instead about Nephrogenic Fibrosing Dermopathy? This really scares me. Nadia 10.4 years ago I can't have an MRI anyway because I have a pacemaker, but this scares the crap out of me. We are getting all these tests, and we don't know what it is doing to our bodies. overthehill 10.4 years ago